Expertise

Sophie advises on litigation before national courts. Further focuses of her practice concern commercial law, in particular the structuring and negotiation of complex agreements and advising on product liability matters.

Vita

Sophie studied in Tübingen, Oslo and Berkeley (LL.M. 2024). She has been with Gleiss Lutz since 2021.

Sophie speaks German, English and French.

Fields
Dispute Resolution, Litigation and Arbitration Commercial Product Liability / Product Compliance
News
Gleiss Lutz advises Ackermans & van Haaren on investment in DISCO Pharmaceuticals Mandate
Gleiss Lutz advises Sumitomo on the acquisition of Bayer's Metribuzin Solo business in Latin America, Asia-Pacific and Canada Mandate
Gleiss Lutz advises medatixx on the acquisition of mediDOK Mandate
Gleiss Lutz advises Exyte on the acquisition of Kinetics Group Mandate
Gleiss Lutz advises Lufthansa on the sale of AirPlus Mandate
Gleiss Lutz advises STEAG and KSBG on group-wide transformation and sale process Mandate

All news

Expertise

Sophie advises on litigation before national courts. Further focuses of her practice concern commercial law, in particular the structuring and negotiation of complex agreements and advising on product liability matters.

Vita

Sophie studied in Tübingen, Oslo and Berkeley (LL.M. 2024). She has been with Gleiss Lutz since 2021.

Sophie speaks German, English and French.

Fields
Dispute Resolution, Litigation and Arbitration Commercial Product Liability / Product Compliance
News
Gleiss Lutz advises Ackermans & van Haaren on investment in DISCO Pharmaceuticals Mandate
Gleiss Lutz advises Sumitomo on the acquisition of Bayer's Metribuzin Solo business in Latin America, Asia-Pacific and Canada Mandate
Gleiss Lutz advises medatixx on the acquisition of mediDOK Mandate
Gleiss Lutz advises Exyte on the acquisition of Kinetics Group Mandate
Gleiss Lutz advises Lufthansa on the sale of AirPlus Mandate
Gleiss Lutz advises STEAG and KSBG on group-wide transformation and sale process Mandate

All news